4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0000950170-24-110810
Chief Financial Officer sold 6,457 shares at an average $7.46 ($48,184)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2024-09-27 | Sale 10b5-1 | −295 | $7.51 | $2,215 | 319,355 | D |
| Catinazzo Thomas Chief Financial Officer | 2024-09-27 | Sale 10b5-1 | −6,162 | $7.46 | $45,969 | 313,193 | D |
| Open-market sales · 6,457 sh · avg $7.46 · $48,184 | |||||||
Loading xslF345X05/ownership.xml…